[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341942-105":59,"doc-detail-341942-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","activating-invasion-and-metastasis-in-small-cell-lung-cancer-role-of-the-tumour-immune-microenvironment-and-mechanisms-of-vasculogenesis-epithelial-mesenchymal-transition-cell-migration-and-organ-tropism","Activating Invasion and Metastasis in Small Cell Lung Cancer - Role of the Tumour Immune Microenvironment and Mechanisms of Vasculogenesis, Epithelial-Mesenchymal Transition, Cell Migration, and Organ Tropism","","Small cell lung cancer (SCLC) shows the most aggressive phenotype among lung cancers, with metastasis contributing substantially to its bleak prognosis. This narrative review summarizes molecular mechanisms that enable activating invasion and metastasis along metastatic pathway steps, including therapeutic targets. It highlights the tumour immune microenvironment in shaping immunotherapy resistance, including reduced natural killer cell infiltration, and links vasculogenesis to VEGF expression and vascular mimicry. It further connects epithelial-mesenchymal transition to E-cadherin transcriptional repression, Notch suppression, and tumour heterogeneity, while describing roles in migration and organ tropism.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/activating-invasion-and-metastasis-in-small-cell-lung-cancer-role-of-the-tumour-immune-microenvironment-and-mechanisms-of-vasculogenesis-epithelial-mesenchymal-transition-cell-migration-and-organ-tropism/341942/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/activating-invasion-and-metastasis-in-small-cell-lung-cancer-role-of-the-tumour-immune-microenvironment-and-mechanisms-of-vasculogenesis-epithelial-mesenchymal-transition-cell-migration-and-organ-tropism/341942.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is metastasis particularly important in small cell lung cancer prognosis?","Question",{"text":112,"@type":113},"SCLC exhibits strong metastatic tendencies that partially explain its highly aggressive phenotype and poor clinical outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role does the tumour immune microenvironment play in SCLC treatment resistance?",{"text":117,"@type":113},"The tumour immune microenvironment promotes immunotherapy resistance, and poor natural killer cell infiltration supports a pro-metastatic environment.",{"name":119,"@type":110,"acceptedAnswer":120},"Which mechanisms support invasion and metastasis in SCLC according to the review?",{"text":121,"@type":113},"Key mechanisms include vasculogenesis via VEGF expression and vascular mimicry, and epithelial-mesenchymal transition driven by E-cadherin repressors, Notch signalling suppression, and tumour heterogeneity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341942,1790586795,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Cancer Reports  \nREVIEW  OPEN ACCESS   \nActivating Invasion and Metastasis in Small  \nCell Lung Cancer: Role of the Tumour Immune Microenvironment and Mechanisms of Vasculogenesis, Epithelial-Mesenchymal Transition, Cell Migration, and Organ Tropism  \nCarl He   \nDepartment of Oncology, Eastern Health, University of Melbourne, Melbourne, Australia  \nCorrespondence: Carl He ([carl.h5810@gmail.com](carl.h5810@gmail.com))  \nReceived: 12 March 2024 | Revised: 6 August 2024 | Accepted: 9 September 2024  \nFunding: The authors received no specific funding for this work.  \nKeywords: epithelial-mesenchymal transition | lung cancer | metastasis | small cell lung cancer  \nABSTRACT  \nBackground: Small cell lung cancer (SCLC) harbours the most aggressive phenotype of all lung cancers to correlate with its bleak prognosis. The aggression of SCLC is partially attributable to its strong metastatic tendencies. The biological processes facilitating the metastasis in SCLC are still poorly understood and garnering a deeper understanding of these processes may enable the exploration of additional targets against this cancer hallmark in the treatment of SCLC.  \nRecent Findings: This narrative review will discuss the proposed molecular mechanisms by which the cancer hallmark of activating invasion and metastasis is featured in SCLC through important steps of the metastatic pathway, and address the various molecular targets that may be considered for therapeutic intervention. The tumour immune microenvironment plays an important role in facilitating immunotherapy resistance, whilst the poor infiltration of natural killer cells in particular fosters a pro-metastatic environment in SCLC. SCLC vasculogenesis is achieved through VEGF expression and vascular mimicry, and epithelial-mesenchymal transition is facilitated by the expression of the transcriptional repressors ofE-cadherin, the suppression of the Notch signalling pathway and tumour heterogeneity. Nuclear factor I/B, selectin and B1 integrin hold important roles in SCLC migration, whilst various molecular markers are expressed by SCLC to assist organ-specific homing during metastasis. The review will also discuss a recent article observing miR-1 mRNA upregulation as a potential therapeutic option in targeting the metastatic activity of SCLC.  \nConclusion: Treatment of SCLC remains a clinical challenge due to its recalcitrant and aggressive nature. Amongst the many hallmarks used by SCLC to enable its aggressive behaviour, that of its ability to invade surrounding tissue and metastasise is particularly notable and understanding the molecular mechanisms in SCLC metastasis can identify therapeutic targets to attenuate SCLC aggression and improve mortality.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.© 2024 The Author(s) . Cancer Reports published by Wiley Periodicals LLC.  \nCancer Reports, 2024; 7:e70018 1 of 11  \n[https://doi.org/10.1002/cnr2.70018](https://doi.org/10.1002/cnr2.70018)  \n1 | Background  \nLung cancer is the foremost contributor to cancer mortality worldwide [1]. Lung cancer is broadly classified as small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), [2] with SCLC accounting for 15% of all lung cancers [3].  \nSCLC, a neuroendocrine tumour of the lung, [4] is the most aggressive lung cancer subtype, [5] characterised by rapid proliferation and metastasis and frequent chemoresistance [6] . Recently, SCLC was subclassified into the subtypes of SCLC-A, N, P and Y according to their high expression of the transcription factors Achaete-scute homologue 1 (ASCL1), neurogenic differentiation 1 (NEUROD1), POU class 2 homeobox 3 (POU2F3) and yes-associated protein 1 (YAP1), respectively [7] . ASCL1 and NEUROD1 are key regulators of neuroendocrine differentiation, conferring a greater neuroendocrine phenotype to SCLC-A and ","cbCait0T0tHRVlgW","https://ap.wps.com/l/cbCait0T0tHRVlgW","pdf",1615730,11,"English","# Background\n# Therapeutic Resistance Mechanisms and the Tumour Immune Microenvironment","[{\"question\":\"Why is metastasis particularly important in small cell lung cancer prognosis?\",\"answer\":\"SCLC exhibits strong metastatic tendencies that partially explain its highly aggressive phenotype and poor clinical outcomes.\"},{\"question\":\"What role does the tumour immune microenvironment play in SCLC treatment resistance?\",\"answer\":\"The tumour immune microenvironment promotes immunotherapy resistance, and poor natural killer cell infiltration supports a pro-metastatic environment.\"},{\"question\":\"Which mechanisms support invasion and metastasis in SCLC according to the review?\",\"answer\":\"Key mechanisms include vasculogenesis via VEGF expression and vascular mimicry, and epithelial-mesenchymal transition driven by E-cadherin repressors, Notch signalling suppression, and tumour heterogeneity.\"}]","Activating Invasion and Metastasis in Small Cell Lung Cancer - Role of the Tumour Immune Microenvironment and Mechanisms of Vasculogenesis, Epithelial-Mesenchymal Transition, Cell Migration, and Organ Tropism | PDF",1790044431,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5a3ffc8b96c50d05a4097dd4e7a8fbf5.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fef1338c54e4785bf2c5071191ecdb47.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9811cf9b6e5883462f53b0c56f21eec4.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e41d2ddac704aaa79a6d12efc2e4317.webp",980,1287]